S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
66,000% upside on tiny biotech? (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
66,000% upside on tiny biotech? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside

7 Sports Betting Stocks That Will Shine Beyond March Madness - 1 of 7

 

#1 - DraftKings (NASDAQ:DKNG)

DraftKings logo

DraftKings (NASDAQ:DKNG) is a logical choice to head this list. The company cites over 4 million users on its daily fantasy sports platform. And a big reason for that is because DraftKings is the official daily fantasy partner of the National Football League (NFL).

Those four million users will go a long way to helping DraftKings meet its forecast to claim over 10% of the total addressable market for online sports betting and iGaming.

Analysts are increasing their price targets for DraftKings. And the stock also has the interest of Cathie Wood, the CEO and Chief Investment Officer of ARK Investment Management who purchased over $433 million of DKNG stock.

 DKNG stock is up over 50% in 2021. This is despite the stock having a sharp selloff on March 16 when the company announced a $1 billion issue of convertible notes. Investors were first concerned about the dilutive effect that such things can produce. But it seems as investors have digested the information, they realize that the company may be raising cash in advance of an acquisition of some sort.

About DraftKings

DraftKings Inc operates a digital sports entertainment and gaming company. It offers multi-channel sports betting and gaming technologies, powering sports and gaming entertainment for operators in 17 countries. The company operates iGaming through its DraftKings brand in 5 states, as well as operates Golden Nugget Online Gaming, an iGaming product and gaming brand in 3 states. Read More 
Current Price
$27.36
Consensus Rating
Moderate Buy
Ratings Breakdown
20 Buy Ratings, 6 Hold Ratings, 4 Sell Ratings.
Consensus Price Target
$33.20 (21.3% Upside)





My Account -